Ischemic Heart Disease Classification and Management

Introduction to Ischemic Heart Disease

The American College of Cardiology and Circulation guidelines propose classifying ischemic heart disease into acute presentations (acute coronary syndromes) and chronic/stable presentations (stable ischemic heart disease), with newer terminology suggesting "acute myocardial ischemic syndromes" (AMIS) and "non-acute myocardial ischemic syndromes" (NAMIS) to encompass both obstructive and non-obstructive causes 1, 2, 3.

The American College of Cardiology recommends that acute coronary syndromes be classified into ST-Elevation Myocardial Infarction (STEMI), Non-ST-Elevation Myocardial Infarction (NSTEMI), and Unstable Angina (UA), based on clinical presentation and diagnostic criteria 4.
Unstable angina patients must be further risk-stratified into high, intermediate, and low-risk categories based on clinical features, ECG changes, and cardiac biomarkers, according to the American College of Cardiology guidelines 4, 5, 6.

High-risk features for unstable angina include prolonged ongoing rest pain, pulmonary edema, new or worsening mitral regurgitation murmur, transient ST-segment changes, and elevated cardiac troponin, as defined by the American College of Cardiology 4, 6.
Intermediate-risk features include prior MI, peripheral or cerebrovascular disease, prolonged rest angina, age over 70, T-wave changes or pathological Q waves on ECG, and slightly elevated troponin, according to the American College of Cardiology guidelines 4, 6.

The American College of Cardiology defines stable angina as predictable chest discomfort with exertion, relieved by rest or nitroglycerin, reflecting gradual progression of obstructive CAD 4, 9.
Asymptomatic IHD is characterized by patients with known coronary disease who become symptom-free with appropriate therapy, as described by the American College of Cardiology and Circulation guidelines 5, 10.

The Circulation guidelines propose a paradigm shift to more inclusive terminology, including acute myocardial ischemic syndromes (AMIS) and non-acute myocardial ischemic syndromes (NAMIS), to encompass both obstructive and non-obstructive causes 1, 2, 3.
AMIS encompasses all acute presentations, including traditional ACS categories, plus recognition of non-obstructive causes, according to the Circulation guidelines 1, 3.

Myocardial infarction is subclassified by mechanism, including Type 1 MI (atherosclerotic plaque rupture) and Type 2 MI (myocardial necrosis from supply-demand mismatch), as defined by the American College of Cardiology and Praxis Medical Insights guidelines 7, 8.

Chest pain characteristics determine initial categorization, including typical angina, atypical angina, and noncardiac chest pain, according to the Annals of Internal Medicine guidelines 9.

The American College of Cardiology and Circulation guidelines emphasize that not all IHD is obstructive coronary disease, and that microvascular dysfunction, vasospasm, and other non-obstructive mechanisms can cause genuine myocardial ischemia and infarction 1, 2, 3.
Low-risk unstable angina overlaps with stable IHD management, and these patients can be managed using stable IHD guidelines rather than requiring acute coronary syndrome protocols, as described by the American College of Cardiology guidelines 4, 5, 6.
Type 2 MI requires different management than Type 1, focusing on correcting the underlying supply-demand mismatch rather than urgent revascularization, according to the Praxis Medical Insights guidelines 7, 8.